“Organisations can apply for a share of £5 million inclusive of VAT. This is to deliver innovations addressing key drug related overdose priorities across two competitions.“
Alex Leach, Acting Director of Innovation and Growth

These are Small Business Research Initiative (SBRI) competitions funded by the Office for Life Sciences (OLS) and the Scottish Health Industry Partnership (SHIP).

These competitions form part of the UK Addiction Healthcare Mission, UK Life Sciences Vision and Scottish Government National Mission to reduce drug related deaths and harms.

OLS and SHIP are investing up to £5 million inclusive of VAT across the two competitions. Their purpose is to develop disruptive, innovative solutions that focus on detecting, responding to, and intervening in, early acute risk of non-fatal and fatal overdose.

Competition 1 – SBRI: Overdose detection, response and intervention feasibility (this competition)

This competition is for feasibility study projects which have not yet reached prototype development. R&D contracts will be up to £100,000 inclusive of VAT, for projects lasting up to 4 months.

This is phase 1 of a potential 2 phase competition. The decision to proceed to phase 2 will depend on success in phase 1 and the assessment of a separate application.

Competition 2 – SBRI: Overdose detection, response and intervention demonstration

This competition is for projects with technology already at an advanced stage of development, and near ready to be deployed in a real-world environment. Up £500,000 inclusive of VAT, will be allocated for each phase 2 project, to develop a prototype product and undertake field testing for up to 12 months.

This is a single-phase competition.

Applications close Friday 21 April 2023 11:00am.

Find out more and apply here.